The biotechnology company Cassava Sciences failed on Wednesday to end a malicious prosecution lawsuit by doctors and ...

Cassava is stopping all development of simufilam in Alzheimer’s disease. Image credit: Shutterstock / Mikadun. Cassava Sciences has officially stopped the development of its investigational drug ...

Cassava Sciences has officially stopped the development of its investigational drug simufilam in Alzheimer’s disease after it failed to show benefit in a second Phase III trial. The company is ...

Cassava Technologies has announced plans to construct Africa’s first AI factory, a state-of-the-art data center facility equipped with NVIDIA’s advanced AI computing technology. The initiative aims to ...

Cassava Sciences has officially ended development of simufilam in Alzheimer’s disease, marking the end of a tumultuous era defined by controversy and failed clinical trials. The company reported the ...

Nvidia and Zimbabwean billionaire Strive Masiyiwa join hands to bring supercomputer technology to the continent.

Cassava Technologies has announced plans to build Africa’s first “AI Factory” — a high-performance, AI-enabled data center powered by NVIDIA’s advanced computing technology. At the ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation. As the company prepares to release trial results, Ben Hargreaves finds that ...

Cassava Technologies has tapped Nvidia to build Africa’s first artificial intelligence "factory". Cassava Technologies, founded by Zimbabwean telecommunications tycoon Strive Masiyiwa, has tapped ...

Another week of escalating tariff talks led to a slump across major U.S. stock market indices for the five-day trading period ...